These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 9269906

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma.
    Nabi U, Nagi AH, Sami W.
    J Ayub Med Coll Abbottabad; 2008; 20(4):44-8. PubMed ID: 19999202
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma.
    Lazaris AC, Theodoropoulos GE, Anastassopoulos P, Nakopoulou L, Panoussopoulos D, Papadimitriou K.
    Histol Histopathol; 1995 Jul; 10(3):661-8. PubMed ID: 7579815
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM, Burgart LJ, Mahoney MR, Windschitl HE, Salim M, Wiesenfeld M, Krook JE, Michalak JC, Goldberg RM, O'Connell MJ, Furth AF, Sargent DJ, Murphy LM, Hill E, Riehle DL, Meyers CH, Witzig TE, North Central Cancer Treatment Group.
    J Clin Oncol; 2004 May 01; 22(9):1572-82. PubMed ID: 15117979
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of p53 and Ki-67 as prognostic factors for survival of men with colorectal cancer.
    Lumachi F, Orlando R, Marino F, Chiara GB, Basso SM.
    Anticancer Res; 2012 Sep 01; 32(9):3965-7. PubMed ID: 22993345
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers.
    Palmqvist R, Sellberg P, Oberg A, Tavelin B, Rutegård JN, Stenling R.
    Br J Cancer; 1999 Feb 01; 79(3-4):577-81. PubMed ID: 10027333
    [Abstract] [Full Text] [Related]

  • 16. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B, Liu CG, Wang MW, Zhao DH, Li Y, Ji XL.
    Chin Med J (Engl); 1992 Mar 01; 105(3):241-6. PubMed ID: 1395845
    [Abstract] [Full Text] [Related]

  • 17. Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma?
    Sory A, Minamoto T, Ohta T, Yamashita K, Sawaguchi K, Mai M, Misiuna P.
    Eur J Surg; 1997 Sep 01; 163(9):685-92. PubMed ID: 9311476
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N.
    Hepatogastroenterology; 1999 Sep 01; 46(28):2648-53. PubMed ID: 10522058
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.